Inhibition of authentic hepatitis C virus replication by sodium stibogluconate
- 1 October 2003
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 310 (2) , 537-541
- https://doi.org/10.1016/j.bbrc.2003.09.055
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Leishmaniasis: new approaches to disease controlBMJ, 2003
- Current therapy for hepatitis C: pegylated interferon and ribavirinClinics in Liver Disease, 2003
- THE DISAPPEARANCE OF TRANSFUSION-TRANSMITTED HEPATITIS C VIRUS INFECTIONS IN THE UNITED STATESClinics in Liver Disease, 2001
- Clinical and Experimental Advances in Treatment of Visceral LeishmaniasisAntimicrobial Agents and Chemotherapy, 2001
- Epidemiology of Hepatitis C: Geographic Differences and Temporal TrendsSeminars in Liver Disease, 2000
- Antiviral Therapy for Patients with Chronic Hepatitis CSeminars in Liver Disease, 2000
- Hepatitis C virus and blood transfusion: past and present risksJournal of Hepatology, 1999
- Sporadic transmission of hepatitis CMedical Hypotheses, 1996
- Recommendations for Treating Leishmaniasis with Sodium Stibogluconate (Pentostam) and Review of Pertinent Clinical StudiesThe American Journal of Tropical Medicine and Hygiene, 1992
- Long-term follow-up of non-A, non-B (type C) post-transfusion hepatitisJournal of Hepatology, 1992